ECM
UTHR icon

ExodusPoint Capital Management’s United Therapeutics UTHR Stock Holding History

ExodusPoint Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-18,102
Closed -$8.82M – 2128
2025
Q4 		$8.82M Sell
18,102
-16,117
-47% -$7.51M 0.07% 294
2025
Q3 		$14.3M Buy
+34,219
New +$11.5M 0.15% 129
2025
Q1 		– Sell
-5,383
Closed -$1.9M – 2026
2024
Q4 		$1.9M Buy
+5,383
New +$1.98M 0.01% 725
2023
Q3 		– Sell
-10,221
Closed -$2.26M – 2171
2023
Q2 		$2.26M Buy
10,221
+3,706
+57% +$821K 0.02% 761
2023
Q1 		$1.46M Sell
6,515
-117,992
-95% -$29.1M 0.01% 1007
2022
Q4 		$34.6M Buy
124,507
+95,310
+326% +$24.1M 0.5% 24
2022
Q3 		$6.11M Sell
29,197
-29,362
-50% -$6.56M 0.08% 341
2022
Q2 		$13.8M Buy
58,559
+32,860
+128% +$6.68M 0.17% 128
2022
Q1 		$4.61M Buy
25,699
+24,108
+1,515% +$4.59M 0.06% 416
2021
Q4 		$344K Sell
1,591
-10,474
-87% -$2.06M ﹤0.01% 1605
2021
Q3 		$2.23M Sell
12,065
-14,991
-55% -$2.95M 0.03% 686
2021
Q2 		$4.85M Buy
27,056
+3,974
+17% +$757K 0.05% 371
2021
Q1 		$3.86M Sell
23,082
-14,106
-38% -$2.35M 0.06% 352
2020
Q4 		$5.64M Buy
37,188
+34,020
+1,074% +$4.46M 0.06% 221
2020
Q3 		$320K Buy
+3,168
New +$348K 0.01% 1250
2020
Q2 		– Sell
-12,017
Closed -$1.14M – 2048
2020
Q1 		$1.14M Buy
12,017
+7,868
+190% +$748K 0.06% 278
2019
Q4 		$365K Sell
4,149
-38,504
-90% -$3.39M 0.01% 1035
2019
Q3 		$3.4M Buy
42,653
+36,171
+558% +$2.91M 0.12% 152
2019
Q2 		$506K Buy
+6,482
New +$606K 0.02% 466

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

ExodusPoint Capital Management's UTHR Position: Q1 2026 in Review

ExodusPoint Capital Management sold out of United Therapeutics (UTHR) in Q1 2026, closing a stake of 18,102 shares — an estimated $8.82M sold.

ExodusPoint Capital Management first reported a position in UTHR in Q2 2019 and held it in 19 quarters. The position peaked at $34.6M in Q4 2022. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • ExodusPoint Capital Management reported no remaining United Therapeutics position as of Q1 2026 after selling out during the quarter.
  • ExodusPoint Capital Management sold 18,102 United Therapeutics shares in Q1 2026, an estimated $8.82M.
  • ExodusPoint Capital Management first reported a position in United Therapeutics in Q2 2019 and held it in 19 quarters.
  • ExodusPoint Capital Management's United Therapeutics position peaked at $34.6M in Q4 2022.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.